raloxifene hydrochloride has been researched along with Vascular Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marc, J; Pfeifer, M; Prezelj, J; Zavratnik, A; Zegura, B | 1 |
| de Valk-de Roo, GW; Duschek, EJ; Lambert, J; Netelenbos, C; Schalkwijk, CG; Stehouwer, CD | 1 |
2 trial(s) available for raloxifene hydrochloride and Vascular Diseases
| Article | Year |
|---|---|
XbaI polymorphism of the estrogen receptor alpha gene influences the effect of raloxifene on the endothelial function.
Topics: Aged; E-Selectin; Endothelium, Vascular; Estrogen Receptor alpha; Female; Humans; Intercellular Adhesion Molecule-1; Middle Aged; Osteoporosis; Polymorphism, Genetic; Prospective Studies; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Vascular Diseases; Vasodilation | 2010 |
Raloxifene, conjugated oestrogen and endothelial function in postmenopausal women.
Topics: Analysis of Variance; Brachial Artery; Designer Drugs; Double-Blind Method; E-Selectin; Endothelium, Vascular; Female; Humans; Middle Aged; Postmenopause; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Vascular Diseases; Vasodilation; von Willebrand Factor | 2003 |